Join GATC Health for an interactive roundtable exploring how AI-driven predictive intelligence is transforming investment strategy in drug development and biotech financing. Discover how the technology platform used by Lloyd's of London is now driving Derisq™ - a new report that delivers validated predictions of safety, efficacy, and non-obvious risk - predicting 11x more accurately than clinical trial outcomes - to provide confidence well before clinical trials begin.
In this session, investors and biopharma leaders will learn how:
- Predictive AI platforms can de-risk portfolios and prioritize high-probability assets
- Detailed predictions (91% specificity, 86% sensitivity) to drive capital efficiency and strategic decision-making
- Innovative risk mitigation approaches, including insurance-backed clinical outcomes through partnerships with Lloyd's of London, are creating new pathways to secure funding
Walk away with actionable insights on leveraging detailed predictive reports that deliver deep insights into unknown risk within 3-4 weeks to support your investment thesis and development strategy - reducing uncertainty and accelerating success.
